Archives

  • Kymera Therapeutics to Present Preclinical Data on its First-in-Class IRAK4 Degraders Demonstrating Robust Inhibition of Inflammatory Responses and Superiority to IRAK4 Kinase Inhibitors

    Kymera Therapeutics Inc., a biotechnology company pioneering targeted protein degradation to discover breakthrough medicines for patients, today announced the company

    Read More
  • JB Chemicals and Pharma reports Q2 net profit at Rs 94 crore

    JB Chemicals and Pharmaceuticals Ltd on Tuesday reported 82 per cent jump in its profit after tax during the second

    Read More
  • Novartis: Phase III PREVENT Trial Met Primary Endpoint Of ASAS40 At Week 16

    Swiss drug major Novartis AG (NVS) announced detailed results from the Phase III PREVENT trial that evaluates the efficacy and

    Read More
  • Yokogawa Acquires Nanopipette Technology from US Venture for Use in Life Science Applications

    Yokogawa Electric Corporation (TOKYO: 6841) announces that it has acquired a nanopipette*1 technology that was developed by BioStinger, Inc., a

    Read More
  • Working as Project Associate at CSIR-IIIM, Jammu

    Post: Project Associate Vacancies- 01 Post Essential Qualification: B.Pharma with atleast 55% marks. 2 years experience in Research and development. Experience: Animal

    Read More

Archive

Offers